Since BCL-2 and MCL-1 proteins may have overlapping anti-apoptotic functions with BCL-XL in cancer cells, we compared the impact of their mRNA expression levels, either alone or in combination with CDK1, CDK6 and WEE1, on the overall survival of TNBC patients. This evidence concerns the gene BCL2 and cancer.